AOD-9604: uses, research, and legal status

What is AOD-9604?

AOD-9604 is a modified fragment corresponding to part of the human growth-hormone molecule. It was originally investigated as a potential anti-obesity treatment.

It is not an FDA-approved drug and is among the peptides under the 2026 compounding review.

How it is thought to work

AOD-9604 was designed to target fat metabolism, in theory supporting fat breakdown without the broader effects of full growth hormone.

What the research shows

Importantly, clinical trials investigating AOD-9604 for obesity did not demonstrate significant weight-loss benefit over placebo. This is a key reason to be cautious about strong claims, and a provider can give an honest assessment.

Studied uses

• Fat-metabolism research
• Body-composition protocols
• Studied without the full range of growth-hormone effects

Legal status in 2026

AOD-9604 is not FDA-approved and is among the peptides under federal review in 2026. No rule has changed yet, and it would remain prescription-only even if reclassified.

How to access AOD-9604 legitimately

A licensed provider can discuss whether AOD-9604 fits your goals given the limited evidence, and where permitted prescribe through a licensed compounding pharmacy.

PeptideForward can match you with vetted telehealth providers who handle these therapies through legitimate channels. The eligibility check takes about five minutes and there is no cost to see if you are a candidate.

Frequently asked questions

Does AOD-9604 cause weight loss? Clinical trials for obesity did not show significant benefit over placebo. Be skeptical of strong weight-loss claims and discuss realistic options with a provider.

Is it legal now? It is not approved. Where permitted it requires a prescription, and its compounding status is under 2026 review.

Does PeptideForward sell it? No. We are an education and matching service only.